Title |
Central sympatholytics prolong survival in experimental sepsis
|
---|---|
Published in |
Critical Care, February 2009
|
DOI | 10.1186/cc7709 |
Pubmed ID | |
Authors |
Stefan Hofer, Jochen Steppan, Tanja Wagner, Benjamin Funke, Christoph Lichtenstern, Eike Martin, Bernhard M Graf, Angelika Bierhaus, Markus A Weigand |
Abstract |
One of the main causes of death in European and US intensive care units is sepsis. It involves a network of pro-inflammatory cytokines such as TNF-alpha, IL-1beta and IL-6. Furthermore, there is an up regulation of transcription factors such as nuclear factor (NF) kappaB. It has previously been shown that clonidine is able to significantly reduce pro-inflammatory cytokines in surgical patients. We therefore hypothesise that the clinically used central alpha-2 agonist clonidine has the ability to improve survival in experimental sepsis by inhibiting the sympathetic tone and consequently inhibiting the pro-inflammatory cytokine release. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 3 | 6% |
United Kingdom | 1 | 2% |
Italy | 1 | 2% |
Netherlands | 1 | 2% |
Unknown | 48 | 89% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 15% |
Other | 6 | 11% |
Student > Postgraduate | 6 | 11% |
Professor > Associate Professor | 6 | 11% |
Student > Ph. D. Student | 5 | 9% |
Other | 12 | 22% |
Unknown | 11 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 36 | 67% |
Nursing and Health Professions | 2 | 4% |
Mathematics | 1 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Immunology and Microbiology | 1 | 2% |
Other | 3 | 6% |
Unknown | 10 | 19% |